Publications by authors named "Charis Armeftis"
Article Synopsis
- The VACCELERATE network is working to improve vaccine research in Europe by making sure everyone's voices are heard and included.
- They wanted to see if people in patient advocacy groups were interested in joining a Volunteer Registry for vaccine studies and what they thought about being part of these trials.
- A survey was sent out in 10 countries and got 520 responses, showing that people care about the risks, benefits, and information about the vaccine trials before they decide to participate.
Background: To date, few cases of TSS caused by coagulase negative (CoN) staphylococci have been reported in the literature. Recent data show that CoN staphylococci are capable of secreting a number of enterotoxins and cytotoxins, normally produced by S. aureus.
View Article and Find Full Text PDFArticle Synopsis
- Asthma affects 5-10% of people globally and this review focuses on updating the understanding of its diagnosis and misdiagnosis.
- A total of 51 recent research articles were analyzed, highlighting the lack of a definitive test for asthma, which contributes to both overdiagnosis and underdiagnosis, impacting patient care and costs.
- Current guidelines stress the importance of a standardized diagnostic approach with objective measures, and more research is needed to improve diagnosis and treatment, particularly for patients with severe asthma.
Background: The pan-European VACCELERATE network aims to implement the first transnational harmonized and sustainable vaccine trial Volunteer Registry, being a single entry point for potential volunteers of large-scale vaccine trials across Europe. This work exhibits a set of harmonized vaccine trial-related educational and promotional tools for the general public, designed and disseminated by the pan-European VACCELERATE network.
Objective: This study primarily aimed to design and develop a standard toolkit to increase positive attitudes and access to trustworthy information for better access and increased recruitment to vaccine trials for the public.